Anne Vanlent

Affiliations

  • at Trevi Therapeutics Inc. (TRVI), 2025-06-13
  • Director at Obseva Sa (OBSV), 2023-01-03
  • Director at Applied Genetic Technologies Corp (AGTC), 2022-12-01
  • Director at Vaxart Inc. (VXRT), 2019-06-14
  • Director at Ocera Therapeutics Inc. (OCRX), 2017-12-11
  • Director at Novelion Therapeutics Inc. (NVLN), 2016-12-27
  • Director at Aegerion Pharmaceuticals Inc. (AEGR), 2016-12-01
  • Director at Onconova Therapeutics Inc. (ONTX), 2015-06-17
  • Director at Integra Lifesciences Holdings Corp (IART), 2012-05-21
  • Director at Penwest Pharmaceuticals Co (PPCO), 2010-11-08
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
TRVI $10.00 5,000 $50,000.00 25,983 2019-05-09 Filing
BOTA $2.20 35,000 $76,891.50 35,000 2015-06-22 Filing
AEGR $35.29 52 $1,835.08 4,000 2014-05-08 Filing
AEGR $34.33 1,948 $66,874.84 3,948 2014-05-08 Filing
AEGR $33.20 2,000 $66,400.00 2,000 2014-05-08 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
IART $47.49 5,270 $250,277.04 3,478 2011-01-13 Filing